Europe · Wires & real time · Reuters Business

India's Torrent Pharma's profit slips as R&D costs outweigh domestic demand

Published by Reuters Business · United Kingdom 9 h ago

Indian drugmaker Torrent Pharmaceuticals reported a near 10% decline in second-quarter profit on Friday, as higher spending on ‌research and development outpaced robust demand…

Read the full article on Reuters Business Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.reuters.com)

Also worth reading

TASS

Tsunami warning issued for Sicily following tremors — newspaper

Anadolu Agency

Türkiye urges stronger financing partnerships to turn COP31 pledges into investment

Reuters US Markets

India's Torrent Pharma's profit slips as R&D costs outweigh domestic demand

Share

Also worth reading

Tsunami warning issued for Sicily following tremors — newspaper

Türkiye urges stronger financing partnerships to turn COP31 pledges into investment

First Russian diesel from Putin-Trump deal heading for US, data shows

Ready for a French test?: Five questions for the ECB

Global equity funds attract inflows for a fifth consecutive week

Mapping the Market: Path to S&P 500 rally strewn with obstacles